BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 37673586)

  • 21. Impact of mesothelioma histologic subtype on outcomes in the Surveillance, Epidemiology, and End Results database.
    Meyerhoff RR; Yang CF; Speicher PJ; Gulack BC; Hartwig MG; D'Amico TA; Harpole DH; Berry MF
    J Surg Res; 2015 Jun; 196(1):23-32. PubMed ID: 25791825
    [TBL] [Abstract][Full Text] [Related]  

  • 22. UD-MIL: Uncertainty-Driven Deep Multiple Instance Learning for OCT Image Classification.
    Wang X; Tang F; Chen H; Luo L; Tang Z; Ran AR; Cheung CY; Heng PA
    IEEE J Biomed Health Inform; 2020 Dec; 24(12):3431-3442. PubMed ID: 32248132
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An Investigation of Cancer-Directed Surgery for Different Histologic Subtypes of Malignant Pleural Mesothelioma.
    Mansur A; Potter AL; Zurovec AJ; Nathamuni KV; Meyerhoff RR; Berry MF; Kang A; Jeffrey Yang CF
    Chest; 2023 May; 163(5):1292-1303. PubMed ID: 36574925
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comments on a recent case-control study of malignant mesothelioma of the pericardium and the tunica vaginalis testis.
    Mezei G; Chang ET; Mowat FS; Moolgavkar SH
    Scand J Work Environ Health; 2021 Jan; 47(1):85-86. PubMed ID: 32626907
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Application of a Neural Network Whole Transcriptome-Based Pan-Cancer Method for Diagnosis of Primary and Metastatic Cancers.
    Grewal JK; Tessier-Cloutier B; Jones M; Gakkhar S; Ma Y; Moore R; Mungall AJ; Zhao Y; Taylor MD; Gelmon K; Lim H; Renouf D; Laskin J; Marra M; Yip S; Jones SJM
    JAMA Netw Open; 2019 Apr; 2(4):e192597. PubMed ID: 31026023
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Asbestos exposure and histological subtype of malignant mesothelioma.
    Franklin P; Alfonso H; Reid A; Olsen N; Shilkin KB; Brims F; de Klerk N; Musk AW
    Occup Environ Med; 2016 Nov; 73(11):749-752. PubMed ID: 27542398
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HEG1 Is a Highly Specific and Sensitive Marker of Epithelioid Malignant Mesothelioma.
    Naso JR; Tsuji S; Churg A
    Am J Surg Pathol; 2020 Aug; 44(8):1143-1148. PubMed ID: 32205484
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Applications of Neural Network-Based Plan-Cancer Method for Primary Diagnosis of Mesothelioma Cancer.
    Kapila D; Panwar S; Raja MKMM; Mondal T; Rafi SM; Singh SP; Kumar B
    Biomed Res Int; 2023; 2023():3164166. PubMed ID: 36785667
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sarcomatoid mesothelioma diagnosed in a patient with mesothelioma in situ: a case report on morphologic differences after 9-month interval with details analysis of cytology in early-stage mesothelioma.
    Yoshida M; Jimbo N; Tsukamoto R; Itoh T; Kawahara K; Mitsui S; Tanaka Y; Maniwa Y
    Diagn Pathol; 2023 Nov; 18(1):126. PubMed ID: 38017544
    [TBL] [Abstract][Full Text] [Related]  

  • 30. EURACAN/IASLC Proposals for Updating the Histologic Classification of Pleural Mesothelioma: Towards a More Multidisciplinary Approach.
    Nicholson AG; Sauter JL; Nowak AK; Kindler HL; Gill RR; Remy-Jardin M; Armato SG; Fernandez-Cuesta L; Bueno R; Alcala N; Foll M; Pass H; Attanoos R; Baas P; Beasley MB; Brcic L; Butnor KJ; Chirieac LR; Churg A; Courtiol P; Dacic S; De Perrot M; Frauenfelder T; Gibbs A; Hirsch FR; Hiroshima K; Husain A; Klebe S; Lantuejoul S; Moreira A; Opitz I; Perol M; Roden A; Roggli V; Scherpereel A; Tirode F; Tazelaar H; Travis WD; Tsao MS; van Schil P; Vignaud JM; Weynand B; Lang-Lazdunski L; Cree I; Rusch VW; Girard N; Galateau-Salle F
    J Thorac Oncol; 2020 Jan; 15(1):29-49. PubMed ID: 31546041
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Malignant Pleural Mesothelioma Epidemiology in the United States From 2000 to 2016.
    Thomas A; Karakattu S; Cagle J; Hoskere G
    Cureus; 2021 Apr; 13(4):e14605. PubMed ID: 34040906
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synchronous diffuse malignant mesothelioma and carcinomas in asbestos-exposed individuals.
    Attanoos RL; Thomas DH; Gibbs AR
    Histopathology; 2003 Oct; 43(4):387-92. PubMed ID: 14511258
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MDM2 and HIF1alpha expression levels in different histologic subtypes of malignant pleural mesothelioma: correlation with pathological and clinical data.
    Pasello G; Urso L; Mencoboni M; Grosso F; Ceresoli GL; Lunardi F; Vuljan SE; Bertorelle R; Sacchetto V; Ciminale V; Rea F; Favaretto A; Conte P; Calabrese F
    Oncotarget; 2015 Dec; 6(39):42053-66. PubMed ID: 26544728
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Shorter Survival in Malignant Pleural Mesothelioma Patients With High PD-L1 Expression Associated With Sarcomatoid or Biphasic Histology Subtype: A Series of 214 Cases From the Bio-MAPS Cohort.
    Brosseau S; Danel C; Scherpereel A; Mazières J; Lantuejoul S; Margery J; Greillier L; Audigier-Valette C; Gounant V; Antoine M; Moro-Sibilot D; Rouquette I; Molinier O; Corre R; Monnet I; Langlais A; Morin F; Bergot E; Zalcman G; Levallet G
    Clin Lung Cancer; 2019 Sep; 20(5):e564-e575. PubMed ID: 31279641
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Malignant Diffuse Mesothelioma in Women: A Study of 354 Cases.
    Pavlisko EN; Liu B; Green C; Sporn TA; Roggli VL
    Am J Surg Pathol; 2020 Mar; 44(3):293-304. PubMed ID: 31876584
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Subtype classification of malignant lymphoma using immunohistochemical staining pattern.
    Hashimoto N; Ko K; Yokota T; Kohno K; Nakaguro M; Nakamura S; Takeuchi I; Hontani H
    Int J Comput Assist Radiol Surg; 2022 Jul; 17(7):1379-1389. PubMed ID: 35147848
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pathology of Malignant Pleural Mesothelioma.
    Hung YP; Chirieac LR
    Thorac Surg Clin; 2020 Nov; 30(4):367-382. PubMed ID: 33012427
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Calretinin as a blood-based biomarker for mesothelioma.
    Johnen G; Gawrych K; Raiko I; Casjens S; Pesch B; Weber DG; Taeger D; Lehnert M; Kollmeier J; Bauer T; Musk AW; Robinson BWS; Brüning T; Creaney J
    BMC Cancer; 2017 May; 17(1):386. PubMed ID: 28558669
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Malignant peritoneal mesothelioma: correlation between CT imaging features and histologic subtypes.
    Atre ID; Watane GV; Harisinghani MG
    Abdom Radiol (NY); 2021 Nov; 46(11):5105-5113. PubMed ID: 34342707
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Malignant peritoneal mesotheliomas of rats induced by multiwalled carbon nanotubes and amosite asbestos: transcriptome and epigenetic profiles.
    Reamon-Buettner SM; Rittinghausen S; Klauke A; Hiemisch A; Ziemann C
    Part Fibre Toxicol; 2024 Jan; 21(1):3. PubMed ID: 38297314
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.